Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Liposome doxorubicin is a commonly used anthracycline anti-tumor drug, and is one of the first-line drugs for ovarian cancer. In North America, the highest incidence of sarcoma, ovarian cancer, breast and liver cancer, and several other cancers is the highest. North America has become a major market due to the existence of advanced healthcare facilities and a high level of patient awareness of the various available treatments.
The report details the trend, potential and market size of Liposomal Doxorubicin market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Liposomal Doxorubicinmarket, defines the market attractiveness level of Liposomal Doxorubicin market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Liposomal Doxorubicin industry, describes the types of Liposomal Doxorubicin market, the applications of major players and the market size, and deeply analyzes the current situation of the global Liposomal Doxorubicin market and the development prospects and opportunities of Liposomal Doxorubicin industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Liposomal Doxorubicin market in Chapter 13.
By Player:
Pfizer
Cadila Pharmaceuticals
Sun Pharmaceutical
Johnson & Johnson
By Type:
Intravenous Infusion
Injection
By End-User:
Academic
Hospitals
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Liposomal Doxorubicin Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Liposomal Doxorubicin Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Liposomal Doxorubicin Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Liposomal Doxorubicin Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Liposomal Doxorubicin Market Analysis and Outlook to 2022
-
7.1 Global Liposomal Doxorubicin Consumption (2017-2022)
-
7.2 United States Liposomal Doxorubicin Consumption (2017-2022)
-
7.3 Europe Liposomal Doxorubicin Consumption (2017-2022)
-
7.4 China Liposomal Doxorubicin Consumption (2017-2022)
-
7.5 Japan Liposomal Doxorubicin Consumption (2017-2022)
-
7.6 India Liposomal Doxorubicin Consumption (2017-2022)
-
7.7 South Korea Liposomal Doxorubicin Consumption (2017-2022)
8 Region and Country-wise Liposomal Doxorubicin Market Analysis and Outlook to 2028
-
8.1 Global Liposomal Doxorubicin Consumption Forecast (2022-2028)
-
8.2 United States Liposomal Doxorubicin Consumption Forecast (2022-2028)
-
8.3 Europe Liposomal Doxorubicin Consumption Forecast (2022-2028)
-
8.4 China Liposomal Doxorubicin Consumption Forecast (2022-2028)
-
8.5 Japan Liposomal Doxorubicin Consumption Forecast (2022-2028)
-
8.6 India Liposomal Doxorubicin Consumption Forecast (2022-2028)
-
8.7 South Korea Liposomal Doxorubicin Consumption Forecast (2022-2028)
9 Global Liposomal Doxorubicin Market Outlook by Types and Applications to 2022
-
9.1 Global Liposomal Doxorubicin Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Intravenous Infusion Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Liposomal Doxorubicin Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Academic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Liposomal Doxorubicin Market Outlook by Types and Applications to 2028
-
10.1 Global Liposomal Doxorubicin Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Intravenous Infusion Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Liposomal Doxorubicin Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Academic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Liposomal Doxorubicin Import and Export Analysis (Top 5 Countries)
-
11.1 Global Liposomal Doxorubicin Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Liposomal Doxorubicin Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Liposomal Doxorubicin Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Liposomal Doxorubicin Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Liposomal Doxorubicin Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Liposomal Doxorubicin Product and Service
-
14.2 Cadila Pharmaceuticals
-
14.2.1 Cadila Pharmaceuticals Company Details
-
14.2.2 Cadila Pharmaceuticals Liposomal Doxorubicin Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Cadila Pharmaceuticals Liposomal Doxorubicin Product and Service
-
14.3 Sun Pharmaceutical
-
14.3.1 Sun Pharmaceutical Company Details
-
14.3.2 Sun Pharmaceutical Liposomal Doxorubicin Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sun Pharmaceutical Liposomal Doxorubicin Product and Service
-
14.4 Johnson & Johnson
-
14.4.1 Johnson & Johnson Company Details
-
14.4.2 Johnson & Johnson Liposomal Doxorubicin Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Johnson & Johnson Liposomal Doxorubicin Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Liposomal Doxorubicin
-
Figure Liposomal Doxorubicin Picture
-
Table Global Liposomal Doxorubicin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liposomal Doxorubicin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liposomal Doxorubicin Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Liposomal Doxorubicin Consumption by Country (2017-2022)
-
Figure United States Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)
-
Table Europe Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)
-
Figure China Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)
-
Figure Japan Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)
-
Figure India Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)
-
Figure South Korea Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)
-
Figure Global Liposomal Doxorubicin Consumption Forecast by Country (2022-2028)
-
Figure United States Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Infusion Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Academic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Infusion Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Liposomal Doxorubicin Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Liposomal Doxorubicin Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Liposomal Doxorubicin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Liposomal Doxorubicin Product and Service
-
Table Cadila Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Cadila Pharmaceuticals Liposomal Doxorubicin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cadila Pharmaceuticals Liposomal Doxorubicin Product and Service
-
Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Liposomal Doxorubicin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Liposomal Doxorubicin Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Liposomal Doxorubicin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Liposomal Doxorubicin Product and Service
-
